Get the Stockscreener App
1.28
3.23%
0.04
After Hours:
1.30
0.02
+1.56%
Renovorx Inc stock is traded at $1.28, with a volume of 1.62M.
It is up +3.23% in the last 24 hours and up +16.36% over the past month.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
See More
Previous Close:
$1.24
Open:
$1.32
24h Volume:
1.62M
Relative Volume:
5.91
Market Cap:
$46.91M
Revenue:
-
Net Income/Loss:
$-9.16M
P/E Ratio:
-2.2456
EPS:
-0.57
Net Cash Flow:
$-8.75M
1W Performance:
+3.23%
1M Performance:
+16.36%
6M Performance:
+35.45%
1Y Performance:
+19.63%
1-Day Range:
$1.255
$1.45
1-Week Range:
$1.06
$1.45
52-Week Range:
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
Name
Renovorx Inc
Sector
Industry
Phone
408-800-2649
Address
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Compare RNXT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.28 | 42.88M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovorx Inc Stock (RNXT) Latest News
Is RenovoRx Inc. stock ready for a breakoutJuly 2025 Reactions & Growth Focused Stock Reports - Newser
Is RenovoRx Inc. forming a reversal patternEarnings Risk Summary & Weekly Setup with High ROI Potential - Newser
Measuring RenovoRx Inc.’s beta against major indicesJuly 2025 Trade Ideas & Verified Entry Point Detection - Newser
What institutional flow reveals about RenovoRx Inc.Portfolio Performance Summary & Real-Time Volume Spike Alerts - Newser
News impact scoring models applied to RenovoRx Inc.2025 Market Overview & Consistent Income Trade Ideas - Newser
Detecting support and resistance levels for RenovoRx Inc.Exit Point & AI Powered Buy/Sell Recommendations - Newser
Is it too late to sell RenovoRx Inc.Weekly Trend Report & Risk Adjusted Swing Trade Ideas - Newser
Will breakout in RenovoRx Inc. lead to full recovery2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
What to expect from RenovoRx Inc. in the next 30 daysJuly 2025 Closing Moves & Momentum Based Trading Signals - Newser
Real time pattern detection on RenovoRx Inc. stockBull Run & Weekly Top Gainers Trade List - Newser
Will RenovoRx Inc. stock go up soon2025 Market Overview & Real-Time Volume Analysis - Newser
How to recover losses in RenovoRx Inc. stockWeekly Trend Recap & Capital Efficiency Focused Ideas - Newser
What earnings revisions data tells us about RenovoRx Inc.2025 Market WrapUp & Accurate Trade Setup Notifications - Newser
RenovoRx, Inc. CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 - Quiver Quantitative
Signal strength of RenovoRx Inc. stock in tech scannersExit Point & AI Enhanced Trading Alerts - Newser
What recovery options are there for RenovoRx Inc.Portfolio Value Report & Real-Time Market Trend Scan - Newser
After-Hours Biotech Gainers: Insider Buys, Trial Updates, And Strategic Deals Fuel Momentum - Nasdaq
Using Python tools to backtest RenovoRx Inc. strategies2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
Key metrics from RenovoRx Inc.’s quarterly dataMarket Trend Report & Risk Adjusted Buy/Sell Alerts - Newser
Using Bollinger Bands to evaluate RenovoRx Inc.2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - Newser
Will RenovoRx Inc. continue its uptrend2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Can volume confirm reversal in RenovoRx Inc.Portfolio Performance Report & Verified Chart Pattern Signals - Newser
Is a relief rally coming for RenovoRx Inc. holdersEarnings Overview Summary & Community Verified Swing Trade Signals - Newser
What’s the recovery path for long term holders of RenovoRx Inc.Weekly Earnings Recap & Proven Capital Preservation Tips - Newser
RenovoRx Inc. stock prediction for this weekGold Moves & Daily Profit Focused Stock Screening - Newser
What indicators show strength in RenovoRx Inc.2025 Volume Leaders & Community Verified Watchlist Alerts - Newser
Is RenovoRx Inc. a defensive stock2025 Market WrapUp & Stepwise Trade Execution Plans - Lancaster City Council
How to use a screener to detect RenovoRx Inc. breakouts2025 Institutional Moves & Weekly Watchlist for Hot Stocks - Newser
Is RenovoRx Inc. stock bottoming out2025 Volume Leaders & Community Consensus Trade Signals - Newser
How high can RenovoRx Inc. stock goJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Multi factor analysis applied to RenovoRx Inc.Watch List & Stepwise Trade Signal Guides - Newser
Renovorx Inc Stock (RNXT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):